Lifecore Biomedical, Inc. De annual operating margin
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2025
Lifecore Biomedical, Inc. De Operating Margin Growth & History (LFCR)
Lifecore Biomedical, Inc. De's operating margin was −0.97% for fiscal 2025.
View full Lifecore Biomedical, Inc. De company overviewLifecore Biomedical, Inc. De annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 · Dec 31 | 2025-12-31 | −0.97% | — |
| 2025 · May 25 | 2025-05-25 | −13.38% | −6.49 pp |
| 2024 | 2024-05-26 | −6.90% | +14.21 pp |
| 2023 | 2023-05-28 | −21.11% | −10.51 pp |
| 2022 | 2022-05-29 | −10.60% | −1.85 pp |
| 2021 | 2021-05-30 | −8.75% | +7.42 pp |
| 2020 | 2020-05-31 | −16.17% | −17.15 pp |
| 2019 | 2019-05-26 | 0.98% | −1.61 pp |
| 2018 | 2018-05-27 | 2.59% | −0.53 pp |
| 2017 | 2017-05-28 | 3.12% | +7.45 pp |
| 2016 | 2016-05-29 | −4.33% | −7.75 pp |
| 2015 | 2015-05-31 | 3.42% | −0.81 pp |
| 2014 | 2014-05-25 | 4.23% | −1.40 pp |
| 2013 | 2013-05-28 | 5.63% | +1.04 pp |
| 2012 | 2012-05-27 | 4.59% | +1.69 pp |
| 2011 | 2011-05-29 | 2.90% | −0.45 pp |
| 2010 | 2010-05-30 | 3.35% | — |
Lifecore Biomedical, Inc. De quarterly operating margin
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q3.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 7.51% | — |
| Q1 2026 | 2026-03-31 | −20.14% | — |
| Q3 2025 · Sep 30 | 2025-09-30 | −9.86% | — |
| Q4 2025 | 2025-05-25 | 14.62% | +8.95 pp |
| Q3 2025 · Feb 23 | 2025-02-23 | −25.68% | −23.18 pp |
| Q2 2025 | 2024-11-24 | −6.02% | −1.10 pp |
| Q1 2025 | 2024-08-25 | −46.89% | −11.76 pp |
| Q4 2024 | 2024-05-26 | 5.67% | +26.99 pp |
| Q3 2024 | 2024-02-25 | −2.51% | +22.11 pp |
| Q2 2024 | 2023-11-26 | −4.92% | +19.56 pp |
| Q1 2024 | 2023-08-27 | −35.13% | −21.33 pp |
| Q4 2023 | 2023-05-28 | −21.32% | −15.55 pp |
| Q3 2023 | 2023-02-26 | −24.61% | +2.74 pp |
| Q2 2023 | 2022-11-27 | −24.48% | −38.89 pp |
| Q1 2023 | 2022-08-28 | −13.80% | +5.11 pp |
| Q4 2022 | 2022-05-29 | −5.76% | −6.50 pp |
| Q3 2022 | 2022-02-27 | −27.36% | −27.62 pp |
| Q2 2022 | 2021-11-28 | 14.41% | +8.64 pp |
| Q1 2022 | 2021-08-29 | −18.91% | +27.84 pp |
| Q4 2021 | 2021-05-30 | 0.74% | +1.03 pp |
| Q3 2021 | 2021-02-28 | 0.26% | +10.08 pp |
| Q2 2021 | 2020-11-29 | 5.78% | +10.01 pp |
| Q1 2021 | 2020-08-30 | −46.76% | −43.60 pp |
| Q4 2020 | 2020-05-31 | −0.29% | −1.91 pp |
| Q3 2020 | 2020-02-23 | −9.82% | −11.90 pp |
| Q2 2020 | 2019-11-24 | −4.23% | −4.24 pp |
| Q1 2020 | 2019-08-25 | −3.16% | −2.95 pp |
| Q4 2019 | 2019-05-26 | 1.62% | −4.10 pp |
| Q3 2019 | 2019-02-24 | 2.08% | −0.32 pp |
| Q2 2019 | 2018-11-25 | 0.01% | +0.58 pp |
| Q1 2019 | 2018-08-26 | −0.21% | −2.56 pp |
| Q4 2018 | 2018-05-27 | 5.72% | +4.40 pp |
| Q3 2018 | 2018-02-25 | 2.40% | −0.94 pp |
| Q2 2018 | 2017-11-26 | −0.57% | −3.53 pp |
| Q1 2018 | 2017-08-27 | 2.35% | −2.66 pp |
| Q4 2017 | 2017-05-28 | 1.32% | −3.30 pp |
| Q3 2017 | 2017-02-26 | 3.35% | +29.21 pp |
| Q2 2017 | 2016-11-27 | 2.96% | +0.96 pp |
| Q1 2017 | 2016-08-28 | 5.02% | +2.11 pp |
| Q4 2016 | 2016-05-29 | 4.62% | +0.01 pp |
| Q3 2016 | 2016-02-28 | −25.87% | −29.35 pp |
| Q2 2016 | 2015-11-29 | 2.00% | −0.94 pp |
| Q1 2016 | 2015-08-30 | 2.91% | +0.26 pp |
| Q4 2015 | 2015-05-31 | 4.61% | +0.23 pp |
| Q3 2015 | 2015-03-01 | 3.49% | −4.21 pp |
| Q2 2015 | 2014-11-30 | 2.93% | +0.29 pp |
| Q1 2015 | 2014-08-31 | 2.64% | +0.84 pp |
| Q4 2014 | 2014-05-25 | 4.39% | — |
| Q3 2014 | 2014-02-23 | 7.70% | +2.05 pp |
| Q2 2014 | 2013-11-24 | 2.65% | −7.03 pp |
| Q1 2014 | 2013-08-25 | 1.80% | −1.14 pp |
| Q3 2013 | 2013-02-24 | 5.65% | +0.61 pp |
| Q2 2013 · Nov 25 | 2012-11-25 | 9.68% | +4.52 pp |
| Q1 2013 | 2012-08-26 | 2.94% | −0.98 pp |
| Q4 2012 | 2012-05-27 | 4.19% | +8.85 pp |
| Q3 2012 | 2012-02-26 | 5.04% | −0.05 pp |
| Q2 2012 | 2011-11-27 | 5.16% | +0.13 pp |
| Q1 2012 | 2011-08-28 | 3.92% | −2.14 pp |
| Q4 2011 | 2011-05-29 | −4.66% | — |
| Q3 2011 | 2011-02-27 | 5.09% | — |
| Q2 2011 | 2010-11-28 | 5.03% | — |
| Q1 2011 | 2010-08-29 | 6.06% | — |
Lifecore Biomedical, Inc. De operating margin trends
Between the periods ended 2010-05-30 and 2025-12-31, Lifecore Biomedical, Inc. De's operating margin decreased from 3.35% to −0.97%, a change of −4.32 percentage points. The latest reported quarter, Q2 2026, shows 7.51%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lifecore Biomedical, Inc. De source filings ↗Community posts
Webster agrees Lifecore buyout with cash and contingent payments
Lifecore Biomedical ($LFCR) has agreed to be acquired by a Webster Equity Partners affiliate. Common shareholders would receive $6.28 in cash per share at closing, a 49.5% premium to the preceding trading day’s close, plus a non-tradable co ...
